EAP treatment completed and Orphan Status achieved for MPS-I
Released
Latest announcements
Ask a question
Your question will be sent privately to Paradigm Biopharmaceuticals. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Paradigm Biopharmaceuticals a question about this announcement.